Does RISANKIZUMAB-RZAA Cause Bronchitis? 283 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 283 reports of Bronchitis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.4% of all adverse event reports for RISANKIZUMAB-RZAA.
283
Reports of Bronchitis with RISANKIZUMAB-RZAA
0.4%
of all RISANKIZUMAB-RZAA reports
1
Deaths
96
Hospitalizations
How Dangerous Is Bronchitis From RISANKIZUMAB-RZAA?
Of the 283 reports, 1 (0.4%) resulted in death, 96 (33.9%) required hospitalization.
Is Bronchitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 283 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Bronchitis?
ADALIMUMAB (3,880)
ETANERCEPT (3,799)
METHOTREXATE (2,233)
TOFACITINIB (2,036)
LENALIDOMIDE (1,998)
OMALIZUMAB (1,785)
HUMAN IMMUNOGLOBULIN G (1,637)
ALBUTEROL (1,525)
ABATACEPT (1,519)
PREDNISONE (1,496)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Bronchitis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA